← 返回

实体瘤的 NK 细胞治疗:NK 细胞治疗及其他领域的当前障碍与未来对策

英文原题:Nature killer cell for solid tumors: Current obstacles and prospective remedies in NK cell therapy and beyond.

查看英文原题

Nature killer cell for solid tumors: Current obstacles and prospective remedies in NK cell therapy and beyond.

PubMed 2024/11/06(内容时间) Crit Rev Oncol Hematol Q1 · IF 6.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

近年来,免疫治疗之后,细胞疗法已成为临床肿瘤管理中的一种创新治疗方法。其中,自然杀伤(NK)细胞疗法在血液系统肿瘤治疗方面取得了重大突破。然而,NK细胞治疗实体瘤的疗效仍面临挑战。随着基因编辑和培养技术的发展及其在NK细胞工程化中的应用,NK细胞疗法有望彻底改变实体瘤治疗。本综述探讨NK细胞的发现和生物学特性、其在肿瘤微环境中的作用,以及NK细胞治疗实体瘤的策略、临床试验、挑战和前景。

展开英文摘要原文

In recent years, cell therapy has emerged as an innovative treatment method for the management of clinical tumors following immunotherapy. Among them, Natural killer (NK) cell therapy has achieved a significant breakthrough in the treatment of hematological tumors.

However, the therapeutic effectiveness of NK cells in the treatment of solid tumors remains challenging. With the progress of gene editing and culture techniques and their application to NK cell engineering, it is expected that NK cell therapy will revolutionize the treatment of solid tumors. In this review, we explore the discovery and biological properties of NK cells, their role in the tumor microenvironment, and the therapeutic strategies, clinical trials, challenges, and prospects of NK cells in the treatment of solid tumors.

论文信息

作者
Tao JH、Zhang J、Li HS、Zhou Y、Guan CX
第一作者单位
Department of Physiology, School of Basic Medical Science, Central South University, Changsha, Hunan 410078, China.China
通讯作者单位
Department of Physiology, School of Basic Medical Science, Central South University, Changsha, Hunan 410078, China. Electronic address: guanchaxiang@csu.edu.cn.China
文献类型
综述
期刊
Critical reviews in oncology/hematology2025 Jan
原文标识
PubMed 39515404 · DOI 10.1016/j.critrevonc.2024.104553